Decision

UK REACH authorisation for Roche Diagnostics Ltd, 3 July 2024

Decision on application for authorisation under UK REACH.

From:
Department for Environment, Food & Rural Affairs
Published
12 August 2024

Documents

PDF, 218 KB, 7 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Decision on an application for authorisation under UK REACH.聽

Substance names聽

4-(1,1,3,3-Tetramethylbutyl)phenol, ethoxylated (4-tert-OPnEO).聽

4-Nonylphenol, branched and linear, ethoxylated (4-NPnEO)鈥�.聽

Authorised use聽

Use of 4-tert-OPnEO and 4-NPnEO in 10 in-vitro diagnostic (IVD) assays used, for example, in clinical chemistry and drug monitoring products.聽

Holder of the authorisation and authorisation number聽

Roche Diagnostics Limited (UKREACH/24/05/0, UKREACH/24/05/1).聽

Date of decision

3 July 2024.

Updates to this page

Published 12 August 2024

Sign up for emails or print this page

Related content